Jazz Pharmaceuticals Ireland Ltd. filed a patent infringement lawsuit alleging that Granules India Ltd.'s submission of an Abbreviated New Drug Application seeking approval to market a generic version of Jazz’s Xywav drug product infringes 14 patents.
The lawsuit alleges infringement of 14 patents for Jazz’s Xywav, the labeling of which instructs use for the treatment of excessive daytime sleepiness in patients with narcolepsy, according to the complaint filed Wednesday in the US District Court for the District of New Jersey. The patents at issue are U.S. Patent Nos. 8,591,922, 8,772,306, 8,901,173, 9,050,302, 9,132,107, 9,486,426, ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.